Abnova FISH probes for cancer research
Abnova provides a collection of fluorescence in situ hybridisation (FISH) probes targeting various potential prognostic biomarkers for oncology. The company’s cytogenetic probes enable high hybridisation efficiency, ready for the rapid identification of chromosomal abnormalities — such as amplifications, translocation, fusion and splitting — that are frequently encountered across the genome.
Designed for the purpose of pinpointing DNA targets in cells and in tissues, the FISH probes will facilitate further research for lung adenocarcinoma, ovarian cancer, pancreatic cancer, prostate cancer and more.
Phone: 02 9698 2022
Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system
The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...
Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit
The kit includes a comprehensive set of optimised screening reagents and conditions that...
Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit
The kit enables simultaneous detection, discrimination and absolute quantification of seven known...